CHEK2 and hepatocellular carcinoma: To further investigate whether HCC cells treated with knockout of CHEK2 and Nutlin-3 could affect various biological processes in HCC through the mitochondrial ATP pathway, we selected Metformin, which acts on several cellular pathways to enhance ATP production in tumor cells via inhibiting complex I of the mitochondrial electron transport chain [22].